Precigen, Inc. (PGEN)
7.585
+0.04
(+0.60%)
USD |
NASDAQ |
Oct 08, 16:00
7.585
0.00 (0.00%)
After-Hours: 20:00
Precigen 30-Day Average Daily Volume : 4.926M for Oct. 7, 2026
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| October 07, 2026 | 4.926M |
| October 06, 2026 | 4.983M |
| October 05, 2026 | 4.923M |
| October 02, 2026 | 4.728M |
| October 01, 2026 | 4.777M |
| September 30, 2026 | 4.895M |
| September 29, 2026 | 4.651M |
| September 28, 2026 | 4.722M |
| September 25, 2026 | 4.871M |
| September 24, 2026 | 4.837M |
| September 23, 2026 | 4.830M |
| September 22, 2026 | 4.807M |
| September 21, 2026 | 4.788M |
| September 18, 2026 | 4.872M |
| September 17, 2026 | 4.795M |
| September 16, 2026 | 5.048M |
| September 15, 2026 | 5.041M |
| September 14, 2026 | 5.196M |
| September 11, 2026 | 5.289M |
| September 10, 2026 | 5.340M |
| September 09, 2026 | 5.364M |
| September 08, 2026 | 5.385M |
| September 04, 2026 | 5.477M |
| September 03, 2026 | 5.500M |
| September 02, 2026 | 5.530M |
| Date | Value |
|---|---|
| September 01, 2026 | 5.543M |
| August 31, 2026 | 5.596M |
| August 28, 2026 | 5.574M |
| August 27, 2026 | 5.583M |
| August 26, 2026 | 5.549M |
| August 25, 2026 | 5.366M |
| August 24, 2026 | 5.268M |
| August 21, 2026 | 5.258M |
| August 20, 2026 | 5.226M |
| August 19, 2026 | 5.064M |
| August 18, 2026 | 4.917M |
| August 17, 2026 | 5.022M |
| August 14, 2026 | 4.985M |
| August 13, 2026 | 4.878M |
| August 12, 2026 | 4.948M |
| August 11, 2026 | 4.941M |
| August 10, 2026 | 4.988M |
| August 07, 2026 | 5.206M |
| August 06, 2026 | 5.193M |
| August 05, 2026 | 5.138M |
| August 04, 2026 | 4.748M |
| August 03, 2026 | 4.766M |
| July 31, 2026 | 4.676M |
| July 30, 2026 | 4.616M |
| July 29, 2026 | 4.616M |
30-Day Average Daily Volume Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
30-Day Average Daily Volume Benchmarks
| Repligen Corp. | 1.152M |
| AC Immune SA | 182052.9 |
| Amgen, Inc. | 2.953M |
| Geron Corp. | 10.38M |
| Neurocrine Biosciences, Inc. | 1.277M |